Bayesian cost‐effectiveness analysis from clinical trial data
- 16 February 2001
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 20 (5) , 733-753
Abstract
A key tool for assessing the relative cost‐effectiveness of two treatments in health economics is the incremental C/E acceptability curve. We present Bayesian computations for this curve in the case where data on both costs and efficacy are available from a clinical trial. Analysis is given under various formulations of prior information. A case study is analysed in which reasonable prior information is shown to strengthen substantially the posterior inference, leading to a more conclusive assessment of cost‐effectiveness. Calculations can be performed using readily available Bayesian software. Copyright © 2001 John Wiley & Sons, Ltd.Keywords
This publication has 19 references indexed in Scilit:
- Inference for the cost-effectiveness acceptability curve and cost-effectiveness ratio.PharmacoEconomics, 2000
- Bayesian estimation of cost-effectiveness ratios from clinical trialsHealth Economics, 1999
- A Bayesian approach to stochastic cost-effectiveness analysisHealth Economics, 1999
- Confidence intervals or surfaces? Uncertainty on the cost-effectiveness planeHealth Economics, 1998
- Net Health BenefitsMedical Decision Making, 1998
- A Note on Confidence Intervals in Cost-Effectiveness AnalysisInternational Journal of Technology Assessment in Health Care, 1998
- Statistical Inference for Cost-Effectiveness RatiosHealth Economics, 1997
- Confidence intervals for cost-effectiveness ratios: An application of Fieller's theoremHealth Economics, 1996
- Confidence intervals for cost/effectiveness ratiosHealth Economics, 1995
- Costs, effects and C/E‐ratios alongside a clinical trialHealth Economics, 1994